Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

Objective: Parkinson’s disease (PD) has significant clinical overlaps with atypical parkinsonism syndromes (APS), which have a poorer treatment response and a more aggressive course than PD. We aimed to identify plasma biomarkers to differentiate PD from APS.Methods: Plasma samples (n = 204) were ob...

Full description

Bibliographic Details
Main Authors: Chin-Hsien Lin, Shieh-Yueh Yang, Herng-Er Horng, Che-Chuan Yang, Jen-Jie Chieh, Hsin-Hsien Chen, Bing-Hsien Liu, Ming-Jang Chiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Aging Neuroscience
Subjects:
Parkinson’s disease
atypical parkinsonism syndrome
α-synuclein
tau
p-Tau181
amyloid beta 42
Online Access:http://journal.frontiersin.org/article/10.3389/fnagi.2018.00123/full

Internet

http://journal.frontiersin.org/article/10.3389/fnagi.2018.00123/full

Similar Items